Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeongrae Kim

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cell Death and Differentiation|March 23, 2021
PARsylated transcription factor EB (TFEB) regulates the expression of a subset of Wnt target genes by forming a complex with β-catenin-TCF/LEF1Soyoung Kim, Gahyeon Song, Taebok Lee, et al.
Pharmaceutics|December 2, 2020
Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell DeathYongwhan Choi, Hong Yeol Yoon, Jeongrae Kim, et al.
Biomaterials|September 26, 2022
Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapyNayeon Shim, Seong Ik Jeon, Suah Yang, et al.
Pharmaceutics|March 26, 2022
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune ResponsesJeongrae Kim, Yongwhan Choi, Suah Yang, et al.
Biomaterials Research|October 16, 2023
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapyJeongrae Kim, Sunejeong Song, Minjun Gwak, et al.
Biomaterials Research|October 18, 2022
Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible lightJiwoong Choi, Il Seong Lee, Ju Seung Lee, et al.
Pharmaceutics|October 27, 2022
Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective ChemotherapyHanhee Cho, Man Kyu Shim, Yujeong Moon, et al.
Biomaterials|April 8, 2021
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicitySuah Yang, Man Kyu Shim, Woo Jun Kim, et al.
ACS Nano|April 29, 2025
Dual Delivery of Light/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma TreatmentJagyeong Goo, Jun Seo Lee, Junwon Park, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cell Death and Differentiation|March 23, 2021
PARsylated transcription factor EB (TFEB) regulates the expression of a subset of Wnt target genes by forming a complex with β-catenin-TCF/LEF1Soyoung Kim, Gahyeon Song, Taebok Lee, et al.
Pharmaceutics|December 2, 2020
Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell DeathYongwhan Choi, Hong Yeol Yoon, Jeongrae Kim, et al.
Biomaterials|September 26, 2022
Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapyNayeon Shim, Seong Ik Jeon, Suah Yang, et al.
Pharmaceutics|March 26, 2022
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune ResponsesJeongrae Kim, Yongwhan Choi, Suah Yang, et al.
Biomaterials Research|October 16, 2023
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapyJeongrae Kim, Sunejeong Song, Minjun Gwak, et al.
Biomaterials Research|October 18, 2022
Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible lightJiwoong Choi, Il Seong Lee, Ju Seung Lee, et al.
Pharmaceutics|October 27, 2022
Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective ChemotherapyHanhee Cho, Man Kyu Shim, Yujeong Moon, et al.
Biomaterials|April 8, 2021
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicitySuah Yang, Man Kyu Shim, Woo Jun Kim, et al.
ACS Nano|April 29, 2025
Dual Delivery of Light/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma TreatmentJagyeong Goo, Jun Seo Lee, Junwon Park, et al.
Pageof 2